-
Cost Implications of Declining MMR Coverage in England: Modeling NHS Burden and the Value of Catch-Up Vaccination
Sep 9, 2025, 16:22 PM -
Drivers and Barriers of Biosimilar Uptake in APAC
Sep 9, 2025, 16:22 PM -
Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada
Sep 9, 2025, 16:22 PM -
Budget and Time Impact Analysis of Introducing Subcutaneous Pembrolizumab to Patients From Institution HCP and Patient Perspectives in the United States (US)
Sep 9, 2025, 16:22 PM -
Integrating Environmental Sustainability Into Cost-Effectiveness Analysis and Value Demonstration: A Multidimensional Framework
Sep 9, 2025, 16:22 PM -
Cost-Minimization Analysis and Economic Impact in EGPA: Evidence From MANDARA
Sep 9, 2025, 16:22 PM -
Patients’ Advocacy Groups in Italy: An Updated Perspective on Activities and Future Directions
Sep 9, 2025, 16:22 PM -
Estimand Framework in the Setting of Observational Studies: Current Landscape and Future Directions
Sep 9, 2025, 16:22 PM -
Expert Consensus on the Clinical and Economic Value of Advanced Wound-Care Products in Mexico: Results From a Delphi Panel
Sep 9, 2025, 16:22 PM -
AI-Assisted Systematic Literature Screening According to NICE, UK, and CDA (Canada) Position Papers: An HTA Submission Use Case
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire
Sep 9, 2025, 16:22 PM -
Describing the Burden of RSV Infection and Subsequent Wheezing in Toddlers: An International Cross-Sectional Study
Sep 9, 2025, 16:22 PM -
A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024
Sep 9, 2025, 16:22 PM -
Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Network Meta-Analysis Comparing Treatments to Paclitaxel
Sep 9, 2025, 16:22 PM -
What Is the Impact of Patient Voice on NICE Recommendations for Drugs Assessed in 2024?
Sep 9, 2025, 16:22 PM -
Disease-Free Survival as a Surrogate Endpoint for Overall Survival in Patients With Adjuvant Treatments for Completely Resected Stage I-III Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses
Sep 9, 2025, 16:22 PM -
Mental and Behavioral Health Disorders MBHD Among Patients With Metastatic and Nonmetastatic Cancer: A Claims-Based Analysis
Sep 9, 2025, 16:22 PM -
Drifting in the Network: Catching Baseline Shifts Before They Wreck Your Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
The Economic Burden of Diabetes-Related Blindness and Vision Impairment in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Comparing Individualized Treatment Effect Inference Methods Through a Simulation Study
Sep 9, 2025, 16:22 PM
